Factors XI and XII as Targets for New Anticoagulants. - Wikidata - wikimedia - TriplyDB

Factors XI and XII as Targets for New Anticoagulants.

Factors XI and XII as Targets for New Anticoagulants.

http://www.wikidata.org/entity/Q37662547

about

An update on factor XI structure and function.Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology

P2860

Q47311661-C97798E2-167E-4C24-99A3-E0A7F352A995 Q55052361-7C6ECD48-A14F-40ED-8A03-FD386FD1D992 Q58571133-1B887172-C0C2-4F61-BE4F-A4D9D9761D35

P2860

Factors XI and XII as Targets for New Anticoagulants.

http://www.wikidata.org/entity/Q37662547

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Factors XI and XII as Targets for New Anticoagulants.

@en

Factors XI and XII as Targets for New Anticoagulants.

@nl

type

label

Factors XI and XII as Targets for New Anticoagulants.

@en

Factors XI and XII as Targets for New Anticoagulants.

@nl

prefLabel

Factors XI and XII as Targets for New Anticoagulants.

@en

Factors XI and XII as Targets for New Anticoagulants.

@nl

P1433

Q37662547-9ED40A7A-BEDF-43D1-AF3F-BF1B6BDAE770

P1476

Q37662547-7D094C87-B9D5-45A5-9D5C-E7A9BB456877

P2093

Q37662547-2EE7521D-2F79-41BF-B74A-B2A383BB3298

Q37662547-C98BE753-26B9-445E-B41F-DFD76D0146DA

P2860

Q37662547-0105CDC6-9067-4A2F-A5FF-2E92AE839478

Q37662547-07C0D7DB-3CCD-44DC-A3ED-3299E54A13BF

Q37662547-0A1660A1-E124-49E5-A4A3-22B669A428ED

Q37662547-16FCE633-8C49-43C3-9C3A-31331E9966A0

Q37662547-1F92B952-E205-4467-88B4-FD354BEC1BBC

Q37662547-26A726A2-3FF7-442B-BB39-6B7A3BCBD945

Q37662547-27E1D769-E9DA-4F0E-AB5A-9AB1A4968171

Q37662547-29632667-4265-4872-834A-F2201B391F8B

Q37662547-29E597EC-28B9-4DF2-84CA-E54BAE9DC23F

Q37662547-2CD32462-2179-4DEE-B419-6104ABEA4DEE

P304

Q37662547-5E0CD47A-9971-41DA-99CE-3796967C254F

P31

Q37662547-8CEF78AB-2C54-443A-BC68-9C35083C4057

P356

Q37662547-45E00F7D-6337-4807-B35A-F04DDDB935CD

P478

Q37662547-091101D1-6342-4173-AB1A-38E6A51B84E6

P577

Q37662547-176DDB7F-CE60-4471-AAAE-290460020C92

P698

Q37662547-8830FC2B-3D65-4240-916B-5A5855EB6440

P921

Q37662547-82CB1D5E-DF55-4EA4-AC32-6FA8CC1CB75D

P932

Q37662547-A81B3647-8EF4-4045-8417-A278E58C9F21

P356

FMED.2017.00019

P1433

Frontiers in medicine

P1476

Factors XI and XII as Targets for New Anticoagulants.

@en

P2093

James C Fredenburgh

http://www.w3.org/2001/XMLSchema#string

Jeffrey I Weitz

http://www.w3.org/2001/XMLSchema#string

P2860

Neutrophil extracellular traps promote deep vein thrombosis in mice

Defective thrombus formation in mice lacking coagulation factor XII

Future prospects for contact factors as therapeutic targets

Factor XI and contact activation as targets for antithrombotic therapy

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors

Dabigatran versus warfarin in patients with mechanical heart valves

A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo

Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Epidemiologic and clinical data linking factors XI and XII to thrombosis.

P304

19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2017.00019

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28286749

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5323386

http://www.w3.org/2001/XMLSchema#string